Mirae Asset Global Investments
ORKA

Mirae Asset Global Investments’s Oruka Therapeutics ORKA Stock Holding History

Mirae Asset Global Investments’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Buy
2,697
+172
+7% +$11.5K ﹤0.01% 1081
2026
Q1 		$124K Buy
2,525
+173
+7% +$6.01K ﹤0.01% 1148
2025
Q4 		$71.3K Buy
2,352
+904
+62% +$25.2K ﹤0.01% 1325
2025
Q3 		$27.8K Buy
1,448
+2
+0.1% +$30 ﹤0.01% 1447
2025
Q2 		$16.2K Buy
1,446
+193
+15% +$2.01K ﹤0.01% 1421
2025
Q1 		$15.7K Buy
1,253
+87
+7% +$1.08K ﹤0.01% 1413
2024
Q4 		$22.2K Buy
+1,166
New +$28.4K ﹤0.01% 1408

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's ORKA Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Oruka Therapeutics (ORKA) stake by 6.8% in Q2 2026, buying an estimated $11.5K and bringing the position to 2,697 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #1081.

Mirae Asset Global Investments first reported a position in ORKA in Q4 2024 and has held it in 7 quarters since. 82 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Mirae Asset Global Investments held 2,697 shares of Oruka Therapeutics worth $257K as of Q2 2026.
  • Mirae Asset Global Investments bought 172 Oruka Therapeutics shares in Q2 2026, an estimated $11.5K.
  • Oruka Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1081 holding.
  • Mirae Asset Global Investments first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 82 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.